Darren Sherman Sells $86.1K of Orchestra BioMed Holdings Inc (OBIO) — SEC Form 4, Nov 03, 2026

Open-Market Net Sale · SEC Form 4

−$86,100

10b5-1 Plan

Equity position changed by -1.3%

Reporting Owner

Darren Sherman

COO

TXN 2026-11-02 · FILED 2026-11-03

Equity Position 1.11M sh 1,121,402 → 1,106,402

Equity Change -1.3% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Orchestra BioMed Holdings Inc

OBIO CIK 0001814114

Reporting Owner

Name	Relationship
Darren Sherman CIK 0001723524	Director COO

Darren Sherman at Orchestra BioMed Holdings Inc Full insider history

Bought (12 mo) $10,660

Sold (12 mo) $439,050

More from this insider at Orchestra BioMed Holdings Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common Stock, par value $0.0001 per share ("Common Stock")F1 F2	2026-11-02	S - Sale 10b5-1	15,000 D	$5.74	-$86,100	1,104,402	Direct

Non-Derivative Holdings

Title	Shares Held	Ownership
Common StockF3	2,000	Indirect By son

Footnotes (3)

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. Show more
F2: The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $5.66 to $5.995. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote. Show more
F3: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Show more